MRPL distributes natural protein bars to children with thalassemia and sickle-cell anaemia, providing essential nutrition for six months.

This summer, the halls of the Renaissance Orlando Resort at SeaWorld® will echo with laughter, music, and the resilient ...

Organizers of the 47th Annual Sickle Cell Softball Tournament held a press conference this afternoon to announce details for ...

The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

European Unitary Patent EP4117446 Validated - Lobe Sciences secures patent protection in 17 EU member states for its DHA and egg yolk-based composition designed to manage Sickle Cell Disease.Covers Al ...

Until recently, a small team issued timely guidance on the types of contraception certain high-risk women should use.

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

Sickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the highest burden seen in people of African, Caribbean, Middle Eastern, and ...

"Vertex reports long-term results for Casgevy in sickle cell and thalassaemia" was originally created and published by ...

Sickle cell disease affects about 100,000 people in the U.S., and 90% of patients are Black, according to NIH.

Vertex Pharmaceuticals unveiled impressive long-term results for its CRISPR/Cas9 gene therapy, PrCASGEVY, at the EHA Congress ...